Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Novel possible psychopharmacologic drugs identified in recent patents

Dec. 20, 2006

Pain perception blocked by SCN9A mutations / News in Context

Dec. 19, 2006

Oral cannabinor completes preclinical toxicology and safety pharmacology studies

Dec. 19, 2006

Aloxi meets endpoints in phase III PONV trials

Dec. 18, 2006

Glenmark to begin phase I trials in Europe for GRC-6211

Dec. 18, 2006

Dainippon Sumitomo Pharma to take on overseas development of lurasidone

Dec. 18, 2006

Oxytrex begins phase III study in subjects prone to opioid dependence

Dec. 18, 2006

Somanta signs letter of intent with Virium for phenylbutyrate

Dec. 18, 2006

Bifeprunox NDA filed for review

Dec. 15, 2006

GSK and Epix establish GPCR collaboration

Dec. 15, 2006

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...